Capricor Therapeutics Inc (CAPR)
17.79
-1.13
(-5.97%)
USD |
NASDAQ |
Nov 21, 16:00
17.76
-0.02
(-0.14%)
After-Hours: 20:00
Capricor Therapeutics Revenue (Quarterly): 2.262M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.262M |
| June 30, 2024 | 3.971M |
| March 31, 2024 | 4.907M |
| December 31, 2023 | 12.09M |
| September 30, 2023 | 6.186M |
| June 30, 2023 | 3.918M |
| March 31, 2023 | 2.987M |
| December 31, 2022 | 0.9599M |
| September 30, 2022 | 1.592M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 0.2041M |
| March 31, 2021 | 0.0408M |
| December 31, 2020 | 0.0578M |
| September 30, 2020 | 0.0169M |
| June 30, 2020 | 0.0499M |
| March 31, 2020 | 0.1857M |
| December 31, 2019 | 0.2221M |
| September 30, 2019 | 0.1421M |
| June 30, 2019 | 0.4104M |
| March 31, 2019 | 0.2305M |
| December 31, 2018 | 0.6481M |
| September 30, 2018 | 0.2192M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.404M |
| March 31, 2018 | 0.4001M |
| December 31, 2017 | 0.4758M |
| September 30, 2017 | 0.3133M |
| June 30, 2017 | 0.9965M |
| March 31, 2017 | 0.8808M |
| December 31, 2016 | 0.6836M |
| September 30, 2016 | 0.6836M |
| June 30, 2016 | 0.9115M |
| March 31, 2016 | 0.9115M |
| December 31, 2015 | 0.9115M |
| September 30, 2015 | 0.9115M |
| June 30, 2015 | 0.9115M |
| March 31, 2015 | 1.042M |
| December 31, 2014 | 1.042M |
| September 30, 2014 | 1.042M |
| June 30, 2014 | 1.042M |
| March 31, 2014 | 1.042M |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | -0.1955M |
| September 30, 2012 | |
| June 30, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0169M
Minimum
Sep 2020
12.09M
Maximum
Dec 2023
2.478M
Average
1.276M
Median
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 10.64B |
| ICU Medical Inc | 589.13M |
| ResMed Inc | 1.225B |
| enVVeno Medical Corp | -- |
| AIM ImmunoTech Inc | 0.035M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.56M |
| Total Expenses (Quarterly) | 15.27M |
| EPS Diluted (Quarterly) | -0.38 |
| Enterprise Value | 723.88M |
| Profit Margin (Quarterly) | -555.2% |
| Earnings Yield | -5.73% |
| Normalized Earnings Yield | -6.082 |